Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Bone and kidney disease: diagnostic and therapeutic implications.

Jamal SA, West SL, Miller PD.

Curr Rheumatol Rep. 2012 Jun;14(3):217-23. doi: 10.1007/s11926-012-0243-9. Review.

PMID:
22350608
[PubMed - indexed for MEDLINE]
2.

Therapy for patients with CKD and low bone mineral density.

Ott SM.

Nat Rev Nephrol. 2013 Nov;9(11):681-92. doi: 10.1038/nrneph.2013.182. Epub 2013 Oct 8. Review.

PMID:
24100401
[PubMed - indexed for MEDLINE]
3.

Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.

Amerling R, Harbord NB, Pullman J, Feinfeld DA.

Blood Purif. 2010;29(3):293-9. doi: 10.1159/000276666. Epub 2010 Jan 21.

PMID:
20090316
[PubMed - indexed for MEDLINE]
4.

Diagnosis and treatment of osteoporosis in chronic renal disease.

Miller PD.

Semin Nephrol. 2009 Mar;29(2):144-55. doi: 10.1016/j.semnephrol.2009.01.007. Review.

PMID:
19371805
[PubMed - indexed for MEDLINE]
5.

Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.

Miller PD.

Curr Osteoporos Rep. 2005 Mar;3(1):5-12. Review.

PMID:
16036095
[PubMed - indexed for MEDLINE]
6.

Bisphophonates in CKD patients with low bone mineral density.

Liu WC, Yen JF, Lang CL, Yan MT, Lu KC.

ScientificWorldJournal. 2013 Dec 31;2013:837573. doi: 10.1155/2013/837573. eCollection 2013. Review.

PMID:
24501586
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].

Okuno S, Ishimura E.

Clin Calcium. 2010 May;20(5):655-62. doi: CliCa1005655662. Review. Japanese.

PMID:
20445276
[PubMed - indexed for MEDLINE]
8.

Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists.

Miller PD.

Curr Rheumatol Rep. 2005 Mar;7(1):53-60. Review.

PMID:
15760581
[PubMed - indexed for MEDLINE]
9.

[Secondary osteoporosis UPDATE. Therapy for bone-mineral disease in CKD-5D patients].

Orita H, Yoshimoto W, Tanaka Y, Yamanaka S, Shigematsu T.

Clin Calcium. 2010 May;20(5):752-7. doi: CliCa1005752757. Review. Japanese.

PMID:
20445287
[PubMed - indexed for MEDLINE]
10.

[Effects of SERMs on bone health. The potential of SERM in the care of chronic kidney disease-mineral bone and disorders].

Hamano T.

Clin Calcium. 2010 Mar;20(3):373-9. doi: CliCa1003373379. Review. Japanese.

PMID:
20190367
[PubMed - indexed for MEDLINE]
11.

[Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Necessity of bone biopsy].

Ito A, Yajima A.

Clin Calcium. 2011 Sep;21(9):1388-92. doi: CliCa110913881392. Review. Japanese.

PMID:
21881202
[PubMed - indexed for MEDLINE]
12.

Chronic kidney disease and bone fracture: a growing concern.

Nickolas TL, Leonard MB, Shane E.

Kidney Int. 2008 Sep;74(6):721-31. doi: 10.1038/ki.2008.264. Epub 2008 Jun 18. Review.

PMID:
18563052
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Management of osteoporosis in CKD Stages 3 to 5.

Gordon PL, Frassetto LA.

Am J Kidney Dis. 2010 May;55(5):941-56. doi: 10.1053/j.ajkd.2010.02.338. Review.

PMID:
20438987
[PubMed - indexed for MEDLINE]
14.

Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Manns BJ, Hodsman A, Zimmerman DL, Mendelssohn DC, Soroka SD, Chan C, Jindal K, Klarenbach S.

Am J Kidney Dis. 2010 May;55(5):800-12. doi: 10.1053/j.ajkd.2010.02.339. No abstract available.

PMID:
20438984
[PubMed - indexed for MEDLINE]
15.

Limitations of dual x-ray absorptiometry in children with chronic kidney disease.

Weber LT, Mehls O.

Pediatr Nephrol. 2010 Jan;25(1):3-5. doi: 10.1007/s00467-009-1248-0. Epub 2009 Jul 15.

PMID:
19603191
[PubMed - indexed for MEDLINE]
16.

Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure.

Orlic L, Crncevic Z, Pavlovic D, Zaputovic L.

Ren Fail. 2010 Jan;32(3):300-8. doi: 10.3109/08860221003611661.

PMID:
20370444
[PubMed - indexed for MEDLINE]
17.

The effect of raloxifene treatment in postmenopausal women with CKD.

Ishani A, Blackwell T, Jamal SA, Cummings SR, Ensrud KE; MORE Investigators.

J Am Soc Nephrol. 2008 Jul;19(7):1430-8. doi: 10.1681/ASN.2007050555. Epub 2008 Apr 9.

PMID:
18400939
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Osteopenia and osteoporosis in gastrointestinal diseases: diagnosis and treatment.

Southerland JC, Valentine JF.

Curr Gastroenterol Rep. 2001 Oct;3(5):399-407. Review.

PMID:
11560797
[PubMed - indexed for MEDLINE]
19.

Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease.

West SL, Jamal SA.

Semin Dial. 2012 Jul;25(4):397-402. doi: 10.1111/j.1525-139X.2012.01096.x. Epub 2012 Jun 11. Review.

PMID:
22686655
[PubMed - indexed for MEDLINE]
20.

Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management?

Bacchetta J, Boutroy S, Juillard L, Vilayphiou N, Guebre-Egziabher F, Pelletier S, Delmas PD, Fouque D.

J Ren Nutr. 2009 Jan;19(1):44-9. doi: 10.1053/j.jrn.2008.10.023.

PMID:
19121770
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk